Pfizer sizes up Russia for opportunities; GAO reports 'lessons' from 2009 pandemic response;

> Pfizer and Russian investor/R&D group ChemRar will explore a collaboration focused on drug research, development and commercialization drugs in Russia and other countries. Article

> A GAO report provides "yet another review of lessons" from the government's response to the H1N1 influenza pandemic, including ongoing spending of the $6.15 billion appropriated. Story

> Delaware is part of a 38-state settlement with GlaxoSmithKline that resolves allegations of substandard manufacturing processes. Article

> PharmAthene says it has achieved a tech milestone in its recombinant anthrax vaccine program: initial technology transfer at the 100-liter scale of its manufacturing process for SparVax to Diosynth in RTP, NC.  PharmAthene announcement

> Document management solutions for pharmaceutical manufacturers are the object of a partnership between NextDocs and Danish IT consultancy NNIT. NextDocs release

> U.K. healthcare logistics specialist Movianto has expanded its cold chain and narcotics handling facility at its Bedford base. Item

> Hyderabad-based Goose has launched Procon Tracker, a track/trace solution to meet regulatory packaging guidelines and detect counterfeits. Goose release

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.